The American Cancer Society predicts that there will be about 164,100 new cases of lung cancer in the United States in the year 2000. Lung cancer is fairly rare in persons under the age of 40. The average age of persons found to have lung cancer is 60.
Small Cell Lung Cancer accounts for about 20% of all lung cancers and is a more aggressive type.
Lung cancer is usually treated with a combination of modalities (i.e., surgery and chemotherapy and radiation) It is becoming more common to undergo a course of radiation or chemotherapy before surgery to reduce the number of cancer cells that may have the potential to spread.
Smoking is the single most important risk factor for the development of lung cancer. Persons who smoke cigarettes, pipes or cigars should consult with their health care provider about methods to quit as soon as possible.
A variety of complementary therapies have been used by persons with all types of cancer to reduce side effects of treatments such as nausea and pain. Biofeedback and other relaxation therapies as well as acupuncture have been used to reduce stress, anxiety and general discomfort.
This MediFocus Guide contains an extensive listing of citations and abstracts of recent journal articles that have been published about this condition in trustworthy medical journals. This is the same type of information that is available to physicians and other health care professionals. A partial selection of journal articles that are abstracted in this MediFocus Guide includes:
Current guidelines for the management of small cell lung cancer. Mayo Clinic Proceedings. 1999
New perspectives for the pharmacological and biological therapy of small cell lung cancer. Critical Reviews in Oncology-Hematology. 1999
Review of selected randomized trials in small cell lung cancer. Seminars in Oncology. 1998
Small-cell lung cancer: treatment progress and prospects. Oncology. 1998
Current therapy of small cell lung cancer. Current Opinion in Oncology. 1998
Prognostic significance of supraclavicular lymph nodes in small cell lung cancer: a study from four consecutive clinical trials, including 1,370 patients. "Petites Cellules" Group. Chest. 1998
Lung cancer in women compared with men: stage, treatment, and survival. Annals of Thoracic Surgery. 1998
Normal serum neuron specific enolase (NSE) value after the first cycle of chemotherapy: an early predictor of complete response and survival in patients with small cell lung carcinoma. Cancer. 1998
Outcome of patients with small-cell lung cancer during 20 years of clinical research at the US National Cancer Institute. Mayo Clinic Proceedings. 1997
Nonpharmacologic management of chemotherapy-induced nausea and vomiting. Oncology Nursing Forum. 1997
MediFocus.com understands that consumers who are facing serious medical issues need access to credible, up-to-date medical information to help them make informed health-care decisions. That's why we've developed the MediFocus Guides...the most advanced and trustworthy patient research guides for over 200 chronic and life-threatening conditions. Each MediFocus Guide includes a detailed overview of the condition including information about diagnosis, treatment options, cutting-edge research, and new developments; excerpts of important journal articles from the current medical literature focusing on standard treatments and treatment options; a directory of leading authors and medical institutions who specialize in the treatment of the condition; and a listing of organizations and support groups where you can obtain additional information about the illness.
MediFocus Guides are the perfect solution for consumers who wish to gain an in-depth understanding of their medical issue and avail themselves of the same type of professional level medical information that is used by physicians and other health-care professionals to help then in the clinical decision making process.
